Mannkind Corporation (MNKD) News
Latest headlines that mention MNKD, newest first · each headline opens the original publisher
- Last price
- $3.13
- Day change
- -2.03%
- Next earnings
- 2026-11-04
MNKD headlines
latest coveragePerformance-based RSUs vested at 83% of target, reflecting MannKind's stock performance against industry benchmarks. Singh retains ~479,000 shares valued at $1.96 million.
Binder's disposition followed vesting of performance-based awards tied to the company's total shareholder return relative to the Russell 3000 Pharmaceutical & Biotechnology Index.
This disposition was tied to vesting of performance-based RSUs at 83% of the target.
Tross disposed of 65,808 shares to cover tax withholding from a vested performance award, retaining over 1 million shares in the company.
Castagna retains 2.4 million shares after the non-discretionary sale tied to RSU vesting, maintaining substantial alignment with the biopharmaceutical company.
MNKD news alerts
Get an alert by email or push when a new headline mentions MNKD.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.